Sentio Systematic Evaluation (SENSE)
Sentio Systematic Evaluation - SENSE
Study Overview
Status
Status
Conditions
Conditions
Intervention / Treatment
Intervention / Treatment
Study Type
Study Type
Enrollment (Estimated)
Enrollment
Contacts and Locations
Study Contact
Study Contact
- Name: Kia N Iversen, PhD
- Phone Number: +46760039141
- Email: kinv@oticonmedical.com
Participation Criteria
Eligibility Criteria
Eligibility Criteria
Ages Eligible for Study
- Child
- Adult
- Older Adult
Accepts Healthy Volunteers
Sampling Method
Study Population
Description
Inclusion Criteria:
- Subject who is scheduled for or have undergone Sentio implantation in clinical practice.
- Subject who has consented to participation or are covered by consent waiver.
Exclusion Criteria:
- Subjects enrolled in other clinical investigations leading to their Sentio implantation and subsequent follow-up deviating substantially from clinical practice
Study Plan
How is the study designed?
Design Details
Number of groups / cohorts
Cohorts and Interventions
Group / CohortGroup / Cohort |
Intervention / TreatmentIntervention / Treatment |
|---|---|
|
Sentio
Patients recieving the Sentio system
|
The Sentio system is an active transcutaneous bone conduction hearing system (single armed study)
|
What is the study measuring?
Primary Outcome Measures
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Rate of succesful use of the device
Time Frame: Completion of the surgical procedure is reported at the surgery. Device specific questionnaire is typically completed within the first year of follow-up, though timing may vary depending on local practice for follow-up.
|
Successful use is defined as a composite outcome consisting of completion of the surgical procedure and patient reported satisfaction after fitting and use of the device (assessed through a device specific questionnaire).
|
Completion of the surgical procedure is reported at the surgery. Device specific questionnaire is typically completed within the first year of follow-up, though timing may vary depending on local practice for follow-up.
|
Secondary Outcome Measures
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Frequency of surgical events and complications
Time Frame: During surgery
|
During surgery
|
|
|
Assess surgical approaches and techniques
Time Frame: During surgery
|
During surgery
|
|
|
Frequency of post-operative complications
Time Frame: From surgery till end of follow-up (expected up to 10 years)
|
From surgery till end of follow-up (expected up to 10 years)
|
|
|
Timing of fitting
Time Frame: During fitting appointment (typically 2-15 weeks after surgery, depending on patient needs and local variations on practice)
|
Days between surgery and fitting of sound processor.
|
During fitting appointment (typically 2-15 weeks after surgery, depending on patient needs and local variations on practice)
|
|
To assess improvement in hearing
Time Frame: At fitting and throughout follow-up period (expected up to 10 years)
|
Free-field thresholds
|
At fitting and throughout follow-up period (expected up to 10 years)
|
Collaborators and Investigators
Sponsor
Sponsor
Study record dates
Study Major Dates
Study Start (Estimated)
Study Start
Primary Completion (Estimated)
Primary Completion
Study Completion (Estimated)
Study Completion
Study Registration Dates
First Submitted
First Submitted
First Submitted That Met QC Criteria
First Submitted That Met QC Criteria
First Posted (Estimated)
First Posted
Study Record Updates
Last Update Posted (Estimated)
Last Update Posted
Last Update Submitted That Met QC Criteria
Last Update Submitted That Met QC Criteria
Last Verified
Last Verified
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
Other Study ID Numbers
- BC125
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
IPD Plan Description
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
Studies a U.S. FDA-regulated device product
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.